(Total Views: 48)
Posted On: 03/04/2021 8:25:48 AM
Post# of 104083
$CYTR News Article - CytRx Highlights Orphazyme's Appointment of New CEO Ahead of Potential Regulatory Approval of Arimoclomol for Niemann-Pick Disease Type C https://marketwirenews.com/news-releases/cytr...30990.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
